speb/financial-data huggingface dataset:
CHCO cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: -1338000.00
CHCO balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 651809000.00
CHCO balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 651809000.00
CHCO income_statement (annual, 2025-12-31) — Normalized Income: 130485000.00
CHCO income_statement (quarterly, 2025-12-31) — Normalized Income: 31358031.01
CHCO income_statement (annual, 2025-12-31) — Occupancy And Equipment: 24008000.00
CHCO income_statement (quarterly, 2025-12-31) — Occupancy And Equipment: 6128000.00
CHCO cash_flow (annual, 2025-12-31) — Operating Cash Flow: 131372000.00
CHCO cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 34345000.00
CHCO cash_flow (annual, 2025-12-31) — Operating Gains Losses: -384000.00
CHCO cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -85000.00
CHCO income_statement (annual, 2025-12-31) — Operating Revenue: 305183000.00
CHCO income_statement (quarterly, 2025-12-31) — Operating Revenue: 78082000.00
CHCO balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 14353935.00
CHCO balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 14353935.00
CHCO balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 8109000.00
CHCO balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 8109000.00
CHCO cash_flow (annual, 2025-12-31) — Other Non Cash Items: -3590000.00
CHCO cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 169000.00
CHCO income_statement (annual, 2025-12-31) — Other Non Interest Expense: 33479000.00
CHCO income_statement (quarterly, 2025-12-31) — Other Non Interest Expense: 9230000.00
CHCO balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 787358000.00
CHCO balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 787358000.00
CHCO income_statement (annual, 2025-12-31) — Otherunder Preferred Stock Dividend: 1157000.00
CHCO income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 293000.00
CHCO cash_flow (annual, 2025-12-31) — Pension And Employee Benefit Expense: -96000.00
CHCO cash_flow (quarterly, 2025-12-31) — Pension And Employee Benefit Expense: -24000.00
CHCO balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
CHCO balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
CHCO income_statement (annual, 2025-12-31) — Pretax Income: 161465000.00
CHCO income_statement (quarterly, 2025-12-31) — Pretax Income: 39541000.00
CHCO cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
CHCO cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 0.00
CHCO income_statement (annual, 2025-12-31) — Professional Expense And Contract Services Expense: 2334000.00
CHCO income_statement (quarterly, 2025-12-31) — Professional Expense And Contract Services Expense: 552000.00
CHCO cash_flow (annual, 2025-12-31) — Purchase Of Investment: -329022000.00
CHCO cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: -60883000.00
CHCO cash_flow (annual, 2025-12-31) — Purchase Of PPE: -2924000.00
CHCO cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -743000.00
CHCO balance_sheet (annual, 2025-12-31) — Receivables: 20718000.00
CHCO balance_sheet (quarterly, 2025-12-31) — Receivables: 20718000.00
CHCO income_statement (annual, 2025-12-31) — Reconciled Depreciation: 11177000.00
CHCO income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 2513000.00
CHCO cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -45760000.00
CHCO cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -16867000.00
CHCO income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 0.00
CHCO balance_sheet (annual, 2025-12-31) — Retained Earnings: 935046000.00
CHCO balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 935046000.00
CHCO income_statement (annual, 2025-12-31) — Salaries And Wages: 79166000.00
CHCO income_statement (quarterly, 2025-12-31) — Salaries And Wages: 20198000.00
CHCO cash_flow (annual, 2025-12-31) — Sale Of Business: 0.00
CHCO cash_flow (annual, 2025-12-31) — Sale Of Investment: 301639000.00
CHCO cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 77914000.00
CHCO cash_flow (annual, 2025-12-31) — Sale Of PPE: 42000.00
CHCO cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 5000.00
CHCO income_statement (annual, 2025-12-31) — Selling And Marketing Expense: 3082000.00
CHCO income_statement (quarterly, 2025-12-31) — Selling And Marketing Expense: 577000.00
CHCO income_statement (annual, 2025-12-31) — Selling General And Administration: 85297000.00
CHCO income_statement (quarterly, 2025-12-31) — Selling General And Administration: 21531000.00
CHCO balance_sheet (annual, 2025-12-31) — Share Issued: 19047548.00
CHCO balance_sheet (quarterly, 2025-12-31) — Share Issued: 19047548.00
CHCO income_statement (annual, 2025-12-31) — Special Income Charges: 0.00
CHCO cash_flow (annual, 2025-12-31) — Stock Based Compensation: 3384000.00
CHCO cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 971000.00
CHCO balance_sheet (annual, 2025-12-31) — Stockholders Equity: 809680000.00
CHCO balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 809680000.00
CHCO balance_sheet (annual, 2025-12-31) — Tangible Book Value: 651809000.00
CHCO balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 651809000.00
CHCO income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CHCO income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 53031.01
CHCO income_statement (annual, 2025-12-31) — Tax Provision: 30980000.00
CHCO income_statement (quarterly, 2025-12-31) — Tax Provision: 7973000.00
CHCO income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.19
CHCO income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.20
CHCO balance_sheet (annual, 2025-12-31) — Total Assets: 6722018000.00
CHCO balance_sheet (quarterly, 2025-12-31) — Total Assets: 6722018000.00
CHCO balance_sheet (annual, 2025-12-31) — Total Capitalization: 959680000.00
CHCO balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 959680000.00
CHCO balance_sheet (annual, 2025-12-31) — Total Debt: 150000000.00
CHCO balance_sheet (quarterly, 2025-12-31) — Total Debt: 150000000.00
CHCO balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 809680000.00
CHCO balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 809680000.00
CHCO balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 5912338000.00
CHCO balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 5912338000.00
CHCO income_statement (annual, 2025-12-31) — Total Unusual Items: 0.00
CHCO income_statement (quarterly, 2025-12-31) — Total Unusual Items: 263000.00
CHCO income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
CHCO income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 263000.00
CHCO balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 4693613.00
CHCO balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 4693613.00
CHCO balance_sheet (annual, 2025-12-31) — Treasury Stock: 270967000.00
CHCO balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 270967000.00
CHCO balance_sheet (annual, 2025-12-31) — Unrealized Gain Loss: -75741000.00
CHCO balance_sheet (quarterly, 2025-12-31) — Unrealized Gain Loss: -75741000.00
CHCO cash_flow (annual, 2025-12-31) — Unrealized Gain Loss On Investment Securities: 401000.00
CHCO cash_flow (quarterly, 2025-12-31) — Unrealized Gain Loss On Investment Securities: 416000.00
CHCO income_statement (quarterly, 2026-03-31) — +Total Revenue: 77129000.00
CHCO balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 21645000.00
CHCO balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 173130000.00
CHCO cash_flow (quarterly, 2026-03-31) — Amortization Cash Flow: 1011000.00
CHCO cash_flow (quarterly, 2026-03-31) — Amortization Of Intangibles: 1011000.00
CHCO balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 29462000.00
CHCO income_statement (quarterly, 2026-03-31) — Basic Average Shares: 14270000.00
CHCO income_statement (quarterly, 2026-03-31) — Basic EPS: 2.20
CHCO cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 191919000.00
CHCO cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -726000.00
CHCO balance_sheet (quarterly, 2026-03-31) — Capital Stock: 47619000.00
CHCO balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 299017000.00
CHCO balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Federal Funds Sold: 299017000.00
CHCO cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -14808000.00
CHCO balance_sheet (quarterly, 2026-03-31) — Cash Financial: 135816000.00
CHCO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 3914000.00
CHCO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: 65176000.00
CHCO cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 38008000.00
CHCO cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: -4339000.00
CHCO cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: 6203000.00
CHCO cash_flow (quarterly, 2026-03-31) — Change In Receivables: -927000.00
CHCO cash_flow (quarterly, 2026-03-31) — Change In Working Capital: 937000.00
CHCO cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -927000.00
CHCO cash_flow (quarterly, 2026-03-31) — Changes In Cash: 107098000.00
CHCO balance_sheet (quarterly, 2026-03-31) — Common Stock: 47619000.00
CHCO cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -14808000.00
CHCO balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 794390000.00
CHCO cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -30862000.00
CHCO cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: -218000.00
CHCO cash_flow (quarterly, 2026-03-31) — Deferred Tax: -218000.00
CHCO cash_flow (quarterly, 2026-03-31) — Depreciation: 1119000.00
CHCO cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 2130000.00
CHCO cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 2130000.00
CHCO income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 14274000.00
CHCO income_statement (quarterly, 2026-03-31) — Diluted EPS: 2.20
CHCO income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 31452000.00
CHCO cash_flow (quarterly, 2026-03-31) — End Cash Position: 299017000.00
CHCO cash_flow (quarterly, 2026-03-31) — Excess Tax Benefit From Stock Based Compensation: 126000.00
CHCO cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 3914000.00
CHCO cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 37282000.00
CHCO income_statement (quarterly, 2026-03-31) — Gain On Sale Of Security: 7000.00
CHCO balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -81263000.00
CHCO income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 20988000.00
CHCO balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 157383000.00
CHCO cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 0.00
CHCO income_statement (quarterly, 2026-03-31) — Insurance And Claims: 805000.00
CHCO income_statement (quarterly, 2026-03-31) — Interest Expense: 19152000.00
CHCO income_statement (quarterly, 2026-03-31) — Interest Income: 78769000.00
CHCO cash_flow (quarterly, 2026-03-31) — Interest Paid Supplemental Data: 19310000.00
CHCO balance_sheet (quarterly, 2026-03-31) — Invested Capital: 944390000.00
CHCO cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: 65176000.00
CHCO balance_sheet (quarterly, 2026-03-31) — Investments And Advances: 772560000.00
CHCO balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 150000000.00
CHCO balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 150000000.00
CHCO cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -185000.00
CHCO balance_sheet (quarterly, 2026-03-31) — Minimum Pension Liabilities: -875000.00
CHCO cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -30862000.00
CHCO income_statement (quarterly, 2026-03-31) — Net Income: 31735000.00
CHCO income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 31452000.00
CHCO income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 31735000.00
CHCO income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 31735000.00
CHCO income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 31735000.00
CHCO cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 31735000.00
CHCO income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 31735000.00
CHCO income_statement (quarterly, 2026-03-31) — Net Interest Income: 59617000.00
CHCO cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 56714000.00
CHCO cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 6966000.00
CHCO cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -185000.00
CHCO cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -1360000.00
CHCO balance_sheet (quarterly, 2026-03-31) — Net PPE: 68740000.00
CHCO cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -726000.00
CHCO cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: 7151000.00
CHCO balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 637007000.00
CHCO income_statement (quarterly, 2026-03-31) — Normalized Income: 31735000.00
CHCO income_statement (quarterly, 2026-03-31) — Occupancy And Equipment: 6297000.00
CHCO cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 38008000.00
CHCO cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: -98000.00
CHCO income_statement (quarterly, 2026-03-31) — Operating Revenue: 77129000.00
CHCO balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 14111466.00
CHCO cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: -381000.00
CHCO income_statement (quarterly, 2026-03-31) — Other Non Interest Expense: 8545000.00
CHCO balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 743098000.00
CHCO income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 283000.00
CHCO cash_flow (quarterly, 2026-03-31) — Pension And Employee Benefit Expense: -42000.00
CHCO balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
CHCO income_statement (quarterly, 2026-03-31) — Pretax Income: 39262000.00
CHCO income_statement (quarterly, 2026-03-31) — Professional Expense And Contract Services Expense: 553000.00
CHCO cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -70000.00
CHCO cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -726000.00
CHCO balance_sheet (quarterly, 2026-03-31) — Receivables: 21645000.00
CHCO income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 2130000.00
CHCO cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -185000.00
CHCO cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -30862000.00
CHCO balance_sheet (quarterly, 2026-03-31) — Retained Earnings: 954407000.00
CHCO income_statement (quarterly, 2026-03-31) — Salaries And Wages: 20183000.00
CHCO cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 56784000.00
CHCO cash_flow (quarterly, 2026-03-31) — Sale Of PPE: 0.00
CHCO income_statement (quarterly, 2026-03-31) — Selling And Marketing Expense: 884000.00
CHCO income_statement (quarterly, 2026-03-31) — Selling General And Administration: 21872000.00
CHCO balance_sheet (quarterly, 2026-03-31) — Share Issued: 19047548.00
CHCO cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 3184000.00
CHCO balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 794390000.00
CHCO balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 637007000.00
CHCO income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
CHCO income_statement (quarterly, 2026-03-31) — Tax Provision: 7527000.00
CHCO income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.19
CHCO balance_sheet (quarterly, 2026-03-31) — Total Assets: 6760269000.00
CHCO balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 944390000.00
CHCO balance_sheet (quarterly, 2026-03-31) — Total Debt: 150000000.00
CHCO balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 794390000.00
CHCO balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 5965879000.00
CHCO balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 4936082.00
CHCO balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 299503000.00
CHCO balance_sheet (quarterly, 2026-03-31) — Unrealized Gain Loss: -80388000.00
CHCO cash_flow (quarterly, 2026-03-31) — Unrealized Gain Loss On Investment Securities: -7000.00
CHCT balance_sheet (annual, 2021-12-31) — Current Debt: 12000000.00
CHCT balance_sheet (annual, 2021-12-31) — Current Debt And Capital Lease Obligation: 12000000.00
CHCT balance_sheet (annual, 2021-12-31) — Derivative Product Liabilities: 5324000.00
CHCT cash_flow (annual, 2021-12-31) — Gain Loss On Investment Securities: -237000.00
CHCT income_statement (annual, 2021-12-31) — Gain On Sale Of Security: 237000.00
CHCT balance_sheet (annual, 2021-12-31) — Non Current Deferred Liabilities: 3791000.00
CHCT balance_sheet (annual, 2021-12-31) — Non Current Deferred Revenue: 3791000.00
CHCT balance_sheet (annual, 2021-12-31) — Non Current Deferred Taxes Assets: 348000.00
CHCT cash_flow (annual, 2021-12-31) — Operating Gains Losses: -237000.00
CHCT income_statement (annual, 2021-12-31) — Other Income Expense: 237000.00
CHCT balance_sheet (annual, 2021-12-31) — Restricted Cash: 516000.00
CHCT income_statement (annual, 2022-12-31) — +Operating Expense: 47176000.00
CHCT income_statement (annual, 2022-12-31) — +Total Revenue: 97679000.00
CHCT balance_sheet (annual, 2022-12-31) — Accounts Receivable: 18108000.00
CHCT balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 625136000.00
CHCT cash_flow (annual, 2022-12-31) — Amortization Cash Flow: 853000.00
CHCT cash_flow (annual, 2022-12-31) — Amortization Of Intangibles: 853000.00
CHCT cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 0.00
CHCT balance_sheet (annual, 2022-12-31) — Assets Held For Sale Current: 0.00
CHCT income_statement (annual, 2022-12-31) — Basic Average Shares: 23631000.00
CHCT income_statement (annual, 2022-12-31) — Basic EPS: 0.81
CHCT cash_flow (annual, 2022-12-31) — Beginning Cash Position: 2867000.00
CHCT cash_flow (annual, 2022-12-31) — Capital Expenditure: -10376000.00
CHCT cash_flow (annual, 2022-12-31) — Capital Expenditure Reported: -10376000.00
CHCT balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 4065000.00
CHCT balance_sheet (annual, 2022-12-31) — Capital Stock: 259000.00
CHCT balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 11233000.00
CHCT balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 11233000.00
CHCT cash_flow (annual, 2022-12-31) — Cash Dividends Paid: -44485000.00
CHCT cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 62693000.00
CHCT cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -113772000.00
CHCT cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: 60280000.00
CHCT cash_flow (annual, 2022-12-31) — Change In Other Current Assets: -1783000.00
CHCT cash_flow (annual, 2022-12-31) — Change In Other Current Liabilities: -579000.00
CHCT cash_flow (annual, 2022-12-31) — Change In Payables And Accrued Expense: 1419000.00
CHCT cash_flow (annual, 2022-12-31) — Change In Working Capital: -943000.00
CHCT cash_flow (annual, 2022-12-31) — Changes In Cash: 9201000.00
CHCT balance_sheet (annual, 2022-12-31) — Common Stock: 259000.00
CHCT balance_sheet (annual, 2022-12-31) — Common Stock Equity: 496814000.00
CHCT cash_flow (annual, 2022-12-31) — Common Stock Issuance: 20544000.00
CHCT income_statement (annual, 2022-12-31) — Cost Of Revenue: 16636000.00
CHCT balance_sheet (annual, 2022-12-31) — Current Assets: 66896000.00
CHCT balance_sheet (annual, 2022-12-31) — Current Deferred Liabilities: 3853000.00
CHCT balance_sheet (annual, 2022-12-31) — Current Deferred Revenue: 3853000.00
CHCT balance_sheet (annual, 2022-12-31) — Current Liabilities: 15230000.00
CHCT cash_flow (annual, 2022-12-31) — Deferred Income Tax: 41000.00
CHCT cash_flow (annual, 2022-12-31) — Deferred Tax: 41000.00
CHCT cash_flow (annual, 2022-12-31) — Depreciation: 32339000.00
CHCT cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 33192000.00
CHCT income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 32339000.00
CHCT cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 33192000.00
CHCT income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 32339000.00
CHCT balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 0.00
CHCT income_statement (annual, 2022-12-31) — Diluted Average Shares: 23631000.00
CHCT income_statement (annual, 2022-12-31) — Diluted EPS: 0.81
CHCT income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 19172000.00
CHCT income_statement (annual, 2022-12-31) — EBIT: 33933000.00
CHCT income_statement (annual, 2022-12-31) — EBITDA: 67125000.00
CHCT cash_flow (annual, 2022-12-31) — End Cash Position: 12068000.00
CHCT balance_sheet (annual, 2022-12-31) — Financial Assets: 22667000.00
CHCT cash_flow (annual, 2022-12-31) — Financing Cash Flow: 62693000.00
CHCT cash_flow (annual, 2022-12-31) — Free Cash Flow: 49904000.00
CHCT balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -209723000.00
CHCT income_statement (annual, 2022-12-31) — General And Administrative Expense: 14837000.00
CHCT balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 2399000.00
CHCT balance_sheet (annual, 2022-12-31) — Gross PPE: 3304000.00
CHCT income_statement (annual, 2022-12-31) — Gross Profit: 81043000.00
CHCT income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 0.00
CHCT income_statement (annual, 2022-12-31) — Interest Expense: 11873000.00
CHCT income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 11873000.00
CHCT income_statement (annual, 2022-12-31) — Interest Income: 66000.00
CHCT income_statement (annual, 2022-12-31) — Interest Income Non Operating: 66000.00
CHCT cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 11237000.00
CHCT balance_sheet (annual, 2022-12-31) — Invested Capital: 849811000.00
CHCT cash_flow (annual, 2022-12-31) — Investing Cash Flow: -113772000.00
CHCT balance_sheet (annual, 2022-12-31) — Investment Properties: 777826000.00
CHCT cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 20544000.00
CHCT cash_flow (annual, 2022-12-31) — Issuance Of Debt: 150000000.00
CHCT balance_sheet (annual, 2022-12-31) — Line Of Credit: 0.00
CHCT balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 4065000.00
CHCT balance_sheet (annual, 2022-12-31) — Long Term Debt: 352997000.00
CHCT balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 357062000.00
CHCT cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 150000000.00
CHCT cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -62130000.00
CHCT cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 20544000.00
CHCT balance_sheet (annual, 2022-12-31) — Net Debt: 341764000.00
CHCT income_statement (annual, 2022-12-31) — Net Income: 22019000.00
CHCT income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 19172000.00
CHCT income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 22019000.00
CHCT income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 22019000.00
CHCT income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 22019000.00
CHCT cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 22019000.00
CHCT income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 22019000.00
CHCT income_statement (annual, 2022-12-31) — Net Interest Income: -11807000.00
CHCT cash_flow (annual, 2022-12-31) — Net Investment Properties Purchase And Sale: -96691000.00
CHCT cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 87870000.00
CHCT cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 87870000.00
CHCT income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -11807000.00
CHCT cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -1236000.00
CHCT cash_flow (annual, 2022-12-31) — Net Other Investing Changes: -6705000.00
CHCT balance_sheet (annual, 2022-12-31) — Net PPE: 3304000.00
CHCT balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 494415000.00
CHCT balance_sheet (annual, 2022-12-31) — Non Current Deferred Assets: 989000.00
CHCT balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Assets: 306000.00
CHCT income_statement (annual, 2022-12-31) — Normalized EBITDA: 67125000.00
CHCT income_statement (annual, 2022-12-31) — Normalized Income: 22019000.00
CHCT balance_sheet (annual, 2022-12-31) — Notes Receivable: 32705000.00
CHCT cash_flow (annual, 2022-12-31) — Operating Cash Flow: 60280000.00
CHCT income_statement (annual, 2022-12-31) — Operating Income: 33867000.00
CHCT income_statement (annual, 2022-12-31) — Operating Revenue: 97679000.00
CHCT balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 25897000.00
CHCT balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -209723000.00
CHCT income_statement (annual, 2022-12-31) — Other Gand A: 14837000.00
CHCT balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 2399000.00
CHCT cash_flow (annual, 2022-12-31) — Other Non Cash Items: -3444000.00
CHCT balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 2344000.00
CHCT balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 7319000.00
CHCT balance_sheet (annual, 2022-12-31) — Other Properties: 3304000.00
CHCT balance_sheet (annual, 2022-12-31) — Other Receivables: 3035000.00
CHCT income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 2847000.00
CHCT balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 11377000.00
CHCT balance_sheet (annual, 2022-12-31) — Preferred Stock: 0.00
CHCT balance_sheet (annual, 2022-12-31) — Prepaid Assets: 980000.00
CHCT income_statement (annual, 2022-12-31) — Pretax Income: 22060000.00
CHCT income_statement (annual, 2022-12-31) — Provision For Doubtful Accounts: 0.00
CHCT cash_flow (annual, 2022-12-31) — Provisionand Write Offof Assets: 0.00
CHCT cash_flow (annual, 2022-12-31) — Purchase Of Investment Properties: -96691000.00
CHCT balance_sheet (annual, 2022-12-31) — Receivables: 53848000.00
CHCT income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 15783000.00
CHCT income_statement (annual, 2022-12-31) — Reconciled Depreciation: 33192000.00
CHCT cash_flow (annual, 2022-12-31) — Repayment Of Debt: -62130000.00
CHCT balance_sheet (annual, 2022-12-31) — Restricted Cash: 835000.00
CHCT balance_sheet (annual, 2022-12-31) — Retained Earnings: 81142000.00
CHCT cash_flow (annual, 2022-12-31) — Sale Of Investment Properties: 0.00
CHCT income_statement (annual, 2022-12-31) — Selling General And Administration: 14837000.00
CHCT balance_sheet (annual, 2022-12-31) — Share Issued: 25897000.00
CHCT income_statement (annual, 2022-12-31) — Special Income Charges: 0.00
CHCT cash_flow (annual, 2022-12-31) — Stock Based Compensation: 9415000.00
CHCT balance_sheet (annual, 2022-12-31) — Stockholders Equity: 496814000.00
CHCT balance_sheet (annual, 2022-12-31) — Tangible Book Value: 494415000.00
CHCT income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
CHCT income_statement (annual, 2022-12-31) — Tax Provision: 41000.00
CHCT income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
CHCT balance_sheet (annual, 2022-12-31) — Total Assets: 876425000.00
CHCT balance_sheet (annual, 2022-12-31) — Total Capitalization: 849811000.00
CHCT balance_sheet (annual, 2022-12-31) — Total Debt: 357062000.00
CHCT balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 496814000.00
CHCT income_statement (annual, 2022-12-31) — Total Expenses: 63812000.00
CHCT balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 379611000.00
CHCT balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 809529000.00
CHCT balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 364381000.00
CHCT income_statement (annual, 2022-12-31) — Total Unusual Items: 0.00
CHCT income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 0.00
CHCT balance_sheet (annual, 2022-12-31) — Working Capital: 51666000.00
CHCT income_statement (annual, 2023-12-31) — +Operating Expense: 67031000.00
CHCT income_statement (annual, 2023-12-31) — +Total Revenue: 112845000.00
CHCT balance_sheet (annual, 2023-12-31) — Accounts Receivable: 23126000.00
CHCT balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 688156000.00
CHCT cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 746000.00
CHCT cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 746000.00
CHCT cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 102000.00
CHCT balance_sheet (annual, 2023-12-31) — Assets Held For Sale Current: 7466000.00
CHCT income_statement (annual, 2023-12-31) — Basic Average Shares: 25202000.00
CHCT income_statement (annual, 2023-12-31) — Basic EPS: 0.20
CHCT cash_flow (annual, 2023-12-31) — Beginning Cash Position: 12068000.00
CHCT cash_flow (annual, 2023-12-31) — Capital Expenditure: -18981000.00
CHCT cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -18981000.00
CHCT balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 4052000.00
CHCT balance_sheet (annual, 2023-12-31) — Capital Stock: 276000.00
CHCT balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 3491000.00
CHCT balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 3491000.00
CHCT cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -48059000.00
CHCT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 44857000.00
CHCT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -113675000.00
CHCT cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 61383000.00
CHCT cash_flow (annual, 2023-12-31) — Change In Other Current Assets: -2950000.00
CHCT cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: -1294000.00
CHCT cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: 859000.00
CHCT cash_flow (annual, 2023-12-31) — Change In Working Capital: -3385000.00
CHCT cash_flow (annual, 2023-12-31) — Changes In Cash: -7435000.00
CHCT balance_sheet (annual, 2023-12-31) — Common Stock: 276000.00
CHCT balance_sheet (annual, 2023-12-31) — Common Stock Equity: 513256000.00
CHCT cash_flow (annual, 2023-12-31) — Common Stock Issuance: 44232000.00
CHCT income_statement (annual, 2023-12-31) — Cost Of Revenue: 20713000.00
CHCT balance_sheet (annual, 2023-12-31) — Current Assets: 70231000.00
CHCT balance_sheet (annual, 2023-12-31) — Current Debt: 50000000.00
CHCT balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 50000000.00
CHCT balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 5378000.00
CHCT balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 5378000.00
CHCT balance_sheet (annual, 2023-12-31) — Current Liabilities: 67410000.00
CHCT cash_flow (annual, 2023-12-31) — Deferred Income Tax: 306000.00
CHCT cash_flow (annual, 2023-12-31) — Deferred Tax: 306000.00
CHCT cash_flow (annual, 2023-12-31) — Depreciation: 39693000.00
CHCT cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 40439000.00
CHCT income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 39693000.00
CHCT cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 40439000.00
CHCT income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 39693000.00
CHCT income_statement (annual, 2023-12-31) — Diluted Average Shares: 25202000.00
CHCT income_statement (annual, 2023-12-31) — Diluted EPS: 0.20
CHCT income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 5095000.00
CHCT income_statement (annual, 2023-12-31) — EBIT: 25812000.00
CHCT income_statement (annual, 2023-12-31) — EBITDA: 66251000.00
CHCT cash_flow (annual, 2023-12-31) — End Cash Position: 4633000.00
CHCT balance_sheet (annual, 2023-12-31) — Financial Assets: 16417000.00
CHCT cash_flow (annual, 2023-12-31) — Financing Cash Flow: 44857000.00
CHCT cash_flow (annual, 2023-12-31) — Free Cash Flow: 42402000.00
CHCT cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: 102000.00
CHCT balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -264032000.00
CHCT income_statement (annual, 2023-12-31) — General And Administrative Expense: 27338000.00
CHCT balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 2645000.00
CHCT balance_sheet (annual, 2023-12-31) — Gross PPE: 3215000.00
CHCT income_statement (annual, 2023-12-31) — Gross Profit: 92132000.00
CHCT income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 102000.00
CHCT income_statement (annual, 2023-12-31) — Interest Expense: 17792000.00
CHCT income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 17792000.00
CHCT income_statement (annual, 2023-12-31) — Interest Income: 813000.00
CHCT income_statement (annual, 2023-12-31) — Interest Income Non Operating: 813000.00
CHCT cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 17114000.00
CHCT balance_sheet (annual, 2023-12-31) — Invested Capital: 916512000.00
CHCT cash_flow (annual, 2023-12-31) — Investing Cash Flow: -113675000.00
CHCT balance_sheet (annual, 2023-12-31) — Investment Properties: 849437000.00
CHCT cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 44232000.00
CHCT cash_flow (annual, 2023-12-31) — Issuance Of Debt: 50000000.00
CHCT balance_sheet (annual, 2023-12-31) — Line Of Credit: 50000000.00
CHCT balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 4052000.00
CHCT balance_sheet (annual, 2023-12-31) — Long Term Debt: 353256000.00
CHCT balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 357308000.00
CHCT cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 50000000.00
CHCT cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -126000.00
CHCT cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 44232000.00
CHCT balance_sheet (annual, 2023-12-31) — Net Debt: 399765000.00
CHCT income_statement (annual, 2023-12-31) — Net Income: 7714000.00
CHCT income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 5095000.00
CHCT income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 7714000.00
CHCT income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 7714000.00
CHCT income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 7714000.00
CHCT cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 7714000.00
CHCT income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 7714000.00
CHCT income_statement (annual, 2023-12-31) — Net Interest Income: -16979000.00
CHCT cash_flow (annual, 2023-12-31) — Net Investment Properties Purchase And Sale: -98897000.00
CHCT cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 49874000.00
CHCT cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 49874000.00
CHCT income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -16979000.00
CHCT cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -1190000.00
CHCT cash_flow (annual, 2023-12-31) — Net Other Investing Changes: 4203000.00
CHCT balance_sheet (annual, 2023-12-31) — Net PPE: 3215000.00
CHCT cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: 50000000.00
CHCT balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 510611000.00
CHCT balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 471000.00
CHCT balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 0.00
CHCT income_statement (annual, 2023-12-31) — Normalized EBITDA: 66353000.00
CHCT income_statement (annual, 2023-12-31) — Normalized Income: 7810900.00
CHCT balance_sheet (annual, 2023-12-31) — Notes Receivable: 30775000.00
CHCT cash_flow (annual, 2023-12-31) — Operating Cash Flow: 61383000.00
CHCT cash_flow (annual, 2023-12-31) — Operating Gains Losses: 102000.00
CHCT income_statement (annual, 2023-12-31) — Operating Income: 25101000.00
CHCT income_statement (annual, 2023-12-31) — Operating Revenue: 112845000.00
CHCT balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 27612732.00
CHCT balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -264032000.00
CHCT income_statement (annual, 2023-12-31) — Other Gand A: 27338000.00
CHCT income_statement (annual, 2023-12-31) — Other Income Expense: -102000.00
CHCT balance_sheet (annual, 2023-12-31) — Other Intangible Assets: 2645000.00
CHCT cash_flow (annual, 2023-12-31) — Other Non Cash Items: -3758000.00
CHCT balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 2996000.00
CHCT balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 7438000.00
CHCT balance_sheet (annual, 2023-12-31) — Other Properties: 3215000.00
CHCT balance_sheet (annual, 2023-12-31) — Other Receivables: 3028000.00
CHCT income_statement (annual, 2023-12-31) — Otherunder Preferred Stock Dividend: 2619000.00
CHCT balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 12032000.00
CHCT balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
CHCT balance_sheet (annual, 2023-12-31) — Prepaid Assets: 1203000.00
CHCT income_statement (annual, 2023-12-31) — Pretax Income: 8020000.00
CHCT income_statement (annual, 2023-12-31) — Provision For Doubtful Accounts: 0.00
CHCT cash_flow (annual, 2023-12-31) — Provisionand Write Offof Assets: 0.00
CHCT cash_flow (annual, 2023-12-31) — Purchase Of Investment Properties: -98897000.00
CHCT balance_sheet (annual, 2023-12-31) — Receivables: 56929000.00
CHCT income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 19967000.00
CHCT income_statement (annual, 2023-12-31) — Reconciled Depreciation: 40439000.00
CHCT cash_flow (annual, 2023-12-31) — Repayment Of Debt: -126000.00
CHCT balance_sheet (annual, 2023-12-31) — Restricted Cash: 1142000.00
CHCT balance_sheet (annual, 2023-12-31) — Retained Earnings: 88856000.00
CHCT cash_flow (annual, 2023-12-31) — Sale Of Investment Properties: 0.00
CHCT income_statement (annual, 2023-12-31) — Selling General And Administration: 27338000.00
CHCT balance_sheet (annual, 2023-12-31) — Share Issued: 27612732.00
CHCT cash_flow (annual, 2023-12-31) — Short Term Debt Issuance: 50000000.00
CHCT income_statement (annual, 2023-12-31) — Special Income Charges: -102000.00
CHCT cash_flow (annual, 2023-12-31) — Stock Based Compensation: 19965000.00
CHCT balance_sheet (annual, 2023-12-31) — Stockholders Equity: 513256000.00
CHCT balance_sheet (annual, 2023-12-31) — Tangible Book Value: 510611000.00
CHCT income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -5100.00
CHCT income_statement (annual, 2023-12-31) — Tax Provision: 306000.00
CHCT income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.05
CHCT balance_sheet (annual, 2023-12-31) — Total Assets: 945412000.00
CHCT balance_sheet (annual, 2023-12-31) — Total Capitalization: 866512000.00
CHCT balance_sheet (annual, 2023-12-31) — Total Debt: 407308000.00
CHCT balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 513256000.00
CHCT income_statement (annual, 2023-12-31) — Total Expenses: 87744000.00
CHCT balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 432156000.00
CHCT balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 875181000.00
CHCT balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 364746000.00
CHCT income_statement (annual, 2023-12-31) — Total Unusual Items: -102000.00
CHCT income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -102000.00
CHCT balance_sheet (annual, 2023-12-31) — Working Capital: 2821000.00
CHCT balance_sheet (quarterly, 2024-09-30) — Accrued Interest Receivable: 1798000.00
CHCT cash_flow (quarterly, 2024-09-30) — Asset Impairment Charge: -5000.00
CHCT cash_flow (quarterly, 2024-09-30) — Deferred Income Tax: 0.00
CHCT cash_flow (quarterly, 2024-09-30) — Deferred Tax: 0.00
CHCT balance_sheet (quarterly, 2024-09-30) — Derivative Product Liabilities: 476000.00
CHCT income_statement (quarterly, 2024-09-30) — Gain On Sale Of Security: 5000.00
CHCT cash_flow (quarterly, 2024-09-30) — Income Tax Paid Supplemental Data: 3000.00
CHCT income_statement (quarterly, 2024-09-30) — Provision For Doubtful Accounts: 0.00
CHCT cash_flow (quarterly, 2024-09-30) — Provisionand Write Offof Assets: 0.00
CHCT balance_sheet (quarterly, 2024-09-30) — Restricted Cash: 0.00
CHCT income_statement (quarterly, 2024-09-30) — Tax Provision: 0.00
CHCT income_statement (annual, 2024-12-31) — +Operating Expense: 72836000.00
CHCT income_statement (annual, 2024-12-31) — +Total Revenue: 115786000.00
CHCT balance_sheet (annual, 2024-12-31) — Accounts Receivable: 24564000.00
CHCT balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 704524000.00
CHCT cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 927000.00
CHCT cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 927000.00
CHCT cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 121000.00
CHCT cash_flow (quarterly, 2024-12-31) — Asset Impairment Charge: -14000.00
CHCT balance_sheet (annual, 2024-12-31) — Assets Held For Sale Current: 6755000.00
CHCT income_statement (annual, 2024-12-31) — Basic Average Shares: 26530000.00
CHCT income_statement (annual, 2024-12-31) — Basic EPS: -0.23
CHCT cash_flow (annual, 2024-12-31) — Beginning Cash Position: 4633000.00
CHCT cash_flow (annual, 2024-12-31) — Capital Expenditure: -24644000.00
CHCT cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -24644000.00
CHCT balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 4025000.00
CHCT balance_sheet (annual, 2024-12-31) — Capital Stock: 282000.00
CHCT balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 4384000.00
CHCT balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 4384000.00
CHCT cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -51698000.00
CHCT cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 33533000.00
CHCT cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -92663000.00
CHCT cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 58881000.00
CHCT cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -3303000.00
CHCT cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 221000.00
CHCT cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 2273000.00
CHCT cash_flow (annual, 2024-12-31) — Change In Working Capital: -809000.00
CHCT cash_flow (annual, 2024-12-31) — Changes In Cash: -249000.00
CHCT balance_sheet (annual, 2024-12-31) — Common Stock: 282000.00
CHCT balance_sheet (annual, 2024-12-31) — Common Stock Equity: 475965000.00
CHCT cash_flow (annual, 2024-12-31) — Common Stock Issuance: 7492000.00
CHCT cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 0.00
CHCT income_statement (annual, 2024-12-31) — Cost Of Revenue: 22834000.00
CHCT balance_sheet (annual, 2024-12-31) — Current Assets: 58108000.00
CHCT balance_sheet (annual, 2024-12-31) — Current Debt: 212000000.00
CHCT balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 212000000.00
CHCT balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 6504000.00
CHCT balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 6504000.00
CHCT balance_sheet (annual, 2024-12-31) — Current Liabilities: 232793000.00
CHCT cash_flow (annual, 2024-12-31) — Deferred Income Tax: 0.00
CHCT cash_flow (quarterly, 2024-12-31) — Deferred Income Tax: 0.00
CHCT cash_flow (annual, 2024-12-31) — Deferred Tax: 0.00
CHCT cash_flow (quarterly, 2024-12-31) — Deferred Tax: 0.00
CHCT cash_flow (annual, 2024-12-31) — Depreciation: 42778000.00
CHCT cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 43705000.00
CHCT income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 42778000.00
CHCT cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 43705000.00
CHCT income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 42778000.00
CHCT income_statement (annual, 2024-12-31) — Diluted Average Shares: 26530000.00
CHCT income_statement (annual, 2024-12-31) — Diluted EPS: -0.23
CHCT income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -5976000.00
CHCT income_statement (annual, 2024-12-31) — EBIT: 20525000.00
CHCT income_statement (annual, 2024-12-31) — EBITDA: 64230000.00
CHCT cash_flow (annual, 2024-12-31) — End Cash Position: 4384000.00
CHCT balance_sheet (annual, 2024-12-31) — Financial Assets: 17631000.00
CHCT cash_flow (annual, 2024-12-31) — Financing Cash Flow: 33533000.00
CHCT cash_flow (annual, 2024-12-31) — Free Cash Flow: 34237000.00
CHCT cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 121000.00
CHCT balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -314516000.00
CHCT income_statement (annual, 2024-12-31) — General And Administrative Expense: 19058000.00
CHCT balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 1932000.00
CHCT balance_sheet (annual, 2024-12-31) — Gross PPE: 3125000.00
CHCT income_statement (annual, 2024-12-31) — Gross Profit: 92952000.00
CHCT income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 121000.00
CHCT income_statement (annual, 2024-12-31) — Interest Expense: 23706000.00
CHCT income_statement (quarterly, 2024-12-31) — Interest Expense: 6405000.00
CHCT income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 23706000.00
CHCT income_statement (annual, 2024-12-31) — Interest Income: 530000.00
CHCT income_statement (annual, 2024-12-31) — Interest Income Non Operating: 530000.00
CHCT cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 23070000.00
CHCT balance_sheet (annual, 2024-12-31) — Invested Capital: 961920000.00
CHCT cash_flow (annual, 2024-12-31) — Investing Cash Flow: -92663000.00
CHCT balance_sheet (annual, 2024-12-31) — Investment Properties: 903322000.00
CHCT cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 7492000.00
CHCT cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
CHCT cash_flow (annual, 2024-12-31) — Issuance Of Debt: 162000000.00
CHCT balance_sheet (annual, 2024-12-31) — Line Of Credit: 212000000.00
CHCT balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 4025000.00
CHCT balance_sheet (annual, 2024-12-31) — Long Term Debt: 273955000.00
CHCT balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 277980000.00
CHCT cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 162000000.00
CHCT cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -79820000.00
CHCT cash_flow (quarterly, 2024-12-31) — Long Term Debt Payments: -75000000.00
CHCT cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 7492000.00
CHCT cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
CHCT balance_sheet (annual, 2024-12-31) — Net Debt: 481571000.00
CHCT income_statement (annual, 2024-12-31) — Net Income: -3181000.00
CHCT income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -5976000.00
CHCT income_statement (annual, 2024-12-31) — Net Income Continuous Operations: -3181000.00
CHCT income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -3181000.00
CHCT income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -3181000.00